Legacy Financial Group (Oklahoma)’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$242K Sell
263
-12
-4% -$12.2K 0.06% 78
2025
Q4
$295K Buy
+275
New +$263K 0.08% 67
2025
Q3
Sell
-261
Closed -$204K 96
2025
Q2
$204K Sell
261
-115
-31% -$89.4K 0.06% 82
2025
Q1
$311K Sell
376
-104
-22% -$86.5K 0.1% 61
2024
Q4
$371K Hold
480
0.12% 58
2024
Q3
$399K Buy
+480
New +$432K 0.14% 54

Other funds holding LLY

Legacy Financial Group (Oklahoma)'s LLY Position: Q1 2026 in Review

Legacy Financial Group (Oklahoma) reduced its Eli Lilly (LLY) stake by 4.4% in Q1 2026, selling an estimated $12.2K and leaving 263 shares worth $242K. The position accounts for 0.06% of the portfolio, ranked #78.

Legacy Financial Group (Oklahoma) first reported a position in LLY in Q3 2024 and has held it in 6 quarters since. The position peaked at $399K in Q3 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Legacy Financial Group (Oklahoma) held 263 shares of Eli Lilly worth $242K as of Q1 2026.
  • Legacy Financial Group (Oklahoma) sold 12 Eli Lilly shares in Q1 2026, an estimated $12.2K.
  • Eli Lilly made up 0.06% of Legacy Financial Group (Oklahoma)'s portfolio in Q1 2026, its #78 holding.
  • Legacy Financial Group (Oklahoma) first reported a position in Eli Lilly in Q3 2024 and has held it in 6 quarters since.
  • Legacy Financial Group (Oklahoma)'s Eli Lilly position peaked at $399K in Q3 2024.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Legacy Financial Group (Oklahoma)'s 13F filing for Q1 2026, filed 27 Apr 2026.